Delivery Order SPE2DB22D3501-SPE2DB26FTJ80
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $22,175.20 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of October 20, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $11,087.70 delivery order to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with performance to be completed by September 23, 2025. This competitively awarded, firm fixed-price contract is being executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.95 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials. This competitively awarded, firm fixed price contract was executed on September 2, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical distributor will perform the delivery at its corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's continued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 15, 2025, for Padcev 30 mg vials with a ceiling value of $83,157.00. This firm fixed price contract, issued by the Defense Logistics Agency's Medical Supply Chain, represents a competitively awarded procurement with no set-aside designation and is scheduled for completion by October 6, 2025. The contract is structured as a child delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,719 to AmerisourceBergen Drug Corp for 30 mg vials of Padcev, a oncology treatment, with performance at the company's Conshohocken, Pennsylvania facility. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025. As a non-set-aside contract, the award reflects AmerisourceBergen's demonstrated capability to compete successfully in federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for PADCEV 20 mg vials, with a ceiling value of $5,543.85 and a firm fixed price arrangement. The order is scheduled for completion by August 27, 2025. This is a non-set-aside, competitively awarded contract supporting the federal government's pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for PADCEV 20 MG vials valued at $3,695.90 by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, leveraging the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTJ80Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for Padcev 20 mg vials on November 4, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order is non-set-aside and competitively awarded, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency. The company's DLA Troop Support Medical contract enables supply of a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. This delivery order for Padcev, a specialized oncology medication, exemplifies AmerisourceBergen's role as a critical vendor in the federal medical procurement process and demonstrates the company's capability to fulfill specialized pharmaceutical requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/4/25 |